Eighty-one-year-old billionaire investor Warren Buffett reportedly received an early stage prostate cancer diagnosis after a blood test for prostate-specific antigen, or P.S.A. Medical journalist Laura Newman discusses why Buffett’s decision to screen and treat his cancer sets a bad precedent.
Segment Guests
Laura Newman
Laura Newman is a medical journalist and author of the Patient POV blog. She’s based in New York, New York.